Leptin-Producing Oncolytic Virus Makes Tumor-Infiltrating T Cells Fit, Not Fat

Guido Kroemer, Laurence Zitvogel

    Résultats de recherche: Contribution à un journalBrève enquêteRevue par des pairs

    5 Citations (Scopus)

    Résumé

    Effective anticancer immunosurveillance after oncolytic viral infection is often hindered by the defective metabolic function of tumor-infiltrating lymphocytes (TILs). A recent paper by Rivadeneira et al. demonstrates that intratumoral delivery of leptin by a recombinant oncolytic vaccinia virus can metabolically enhance TIL effector and memory functions through improved mitochondrial oxidative phosphorylation, thereby enhancing therapeutic efficacy.

    langue originaleAnglais
    Pages (de - à)423-425
    Nombre de pages3
    journalImmunity
    Volume51
    Numéro de publication3
    Les DOIs
    étatPublié - 17 sept. 2019

    Contient cette citation